| Entry |
|
| Name |
Formoterol (INN);
Oxis (TN)
|
| Formula |
C19H24N2O4
|
| Exact mass |
344.1736
|
| Mol weight |
344.4049
|
| Structure |

     |
| Activity |
Bronchodilator;
beta2-Sympathomimetic [DS: H00079]
|
| Remark |
|
| Comment |
Long-acting beta-adrenoceptor agonist (LABA)
|
| Target |
beta2-adrenergic receptor agonist [HSA: 154] [KO: K04142] |
| Pathway |
|
| Metabolism |
|
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AC Selective beta-2-adrenoreceptor agonists
R03AC13 Formoterol
D07990 Formoterol (INN)
USP drug classification [BR:br08302]
Respiratory Tract Agents
Bronchodilators, Sympathomimetic
Formoterol
D07990 Formoterol (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
beta2-adrenergic receptor [HSA:154] [KO:K04142]
Formoterol [ATC:R03AC13]
D07990 Formoterol (INN)
 |
| Other DBs |
CAS: 73573-87-2 PubChem: DrugBank: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 25
1 C8y C 24.5700 -21.2100
2 C8x C 23.3800 -21.9100
3 C8x C 24.5700 -19.8100
4 C1c C 25.7600 -21.9100
5 C8y C 22.1200 -21.2100
6 C8x C 23.3800 -19.1100
7 C1b C 27.0200 -21.2100
8 O1a O 25.7600 -23.3100
9 C8y C 22.1200 -19.8100
10 N1b N 20.9300 -21.9100
11 N1b N 28.2100 -21.9100
12 O1a O 20.9300 -19.1100
13 C4a C 19.7400 -21.2100
14 C1c C 29.4000 -21.2100
15 O4a O 18.4800 -21.9100
16 C1b C 30.5900 -21.9100
17 C1a C 29.4000 -19.8100
18 C8y C 31.8500 -21.2100
19 C8x C 31.8500 -19.8100
20 C8x C 33.0400 -21.9100
21 C8x C 33.0400 -19.1100
22 C8x C 34.2300 -21.2100
23 C8y C 34.2300 -19.8100
24 O2a O 35.4900 -19.0400
25 C1a C 36.6800 -19.7400
BOND 26
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 4 8 1
8 5 9 2
9 5 10 1
10 7 11 1
11 9 12 1
12 10 13 1
13 11 14 1
14 13 15 2
15 14 16 1
16 14 17 1
17 16 18 1
18 18 19 2
19 18 20 1
20 19 21 1
21 20 22 2
22 21 23 2
23 23 24 1
24 24 25 1
25 6 9 1
26 22 23 1
|